Mogamulizumab in a patient with Sézary syndrome and severe atopic dermatitis

Eur J Cancer. 2021 Oct:156 Suppl 1:S51-S52. doi: 10.1016/S0959-8049(21)00721-8.

Authors

Florent Amatore¹, Emily Connell¹, Marie Aymonier¹, Caroline Gaudy-Marqueste¹, Marie-Aleth Richard¹

Affiliation

¹ Department of Dermatology and Skin Cancers, Hôpital de la Timone, Aix-Marseille Université, Marseille, France.

PMID: 34649662
DOI: 10.1016/S0959-8049(21)00721-8

No abstract available

Keywords: CCR4; Mogamulizumab; atopic dermatitis.